RE:PMN 310 Clinical TrialYes, bball you did care before when Acumen was on Promis's corporate presentations for months. They don't look a like a fly by company had 210 million in cash at the end of June. Actual study start June 2021 first patient dose October 2021.
BBall you are saying PMN making IND application in December, 30 day approval, dosing to begin in January or Feburary? Really quite incredible for anyone to believe, have they started recruitment doubtful before approvals. Is Promis planning like retiredcop said to pay university or med students who don't have alzheimers, to get that gathered up in less than 30 days to begin in January? You would think that there would be a screening and vetting process like all other companies for the patients trials.
However you are pointing some important information not made public, Promis has developed a proprietary blood biomarker test, and the fact they have indicated they may do another financing in the phase 1b trial.